A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF)
ACTIVE_NOT_RECRUITING
Status
Conditions
- Desmoid Tumor
- Aggressive Fibromatosis
Interventions
- DRUG: Nirogacestat oral tablet
Sponsor
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany